S. Française-de-rhumatologie, Dossier Polyarthrite rhumatoïde http://www.rhumatologie.asso.fr/04-Rhumatismes/grandes-maladies/0D-dossier- polyarthrite/sommaire-polyarthrite.asp, 2006.

L. Cantagrel, L. Chary-valckenaere, R. M. Euller-ziegler, R. Flipo, J. M. Juvin et al., Prevalence of rheumatoid arthritis in France, Ann Rheum Dis, issue.10, pp.64-1427, 2001.

L. Carmona, V. Villaverde, C. Hernandez-garcia, J. Ballina, R. Gabriel et al., The prevalence of rheumatoid arthritis in the general population of Spain, Rheumatology, vol.41, issue.1, pp.4188-95, 2002.
DOI : 10.1093/rheumatology/41.1.88

D. Symmons, G. Turner, R. Web, P. Asten, E. Barrett et al., The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century, Rheumatology, vol.41, issue.7, pp.41793-800, 2002.
DOI : 10.1093/rheumatology/41.7.793

S. E. Gabriel, C. S. Crowson, and W. M. O-'fallon, The epidemiology of rheumatoid arthritis in Rochester, Minnesota, Arthritis Rheum, issue.3, pp.1955-1985, 1999.

F. Guillemin, S. Briançon, J. M. Klein, E. Sauleau, and J. , Low Incidence of Rheumatoid Arthritis in France, Scandinavian Journal of Rheumatology, vol.33, issue.59, pp.264-268, 1994.
DOI : 10.3109/03009749409103727

P. K. Gregersen, J. Silver, and R. J. Winchester, The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis & Rheumatism, vol.4, issue.11, pp.301205-12013, 1987.
DOI : 10.1002/art.1780301102

D. Reviron, A. Perdriger, E. Toussirot, D. Wendling, N. Balandraud et al., Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis, Arthritis Rheum, issue.3, pp.44-535, 2001.

H. An, -derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs, J Immunol, vol.166, issue.8, pp.4987-4993, 2001.
URL : https://hal.archives-ouvertes.fr/hal-00758194

. Gene-gene, and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis, Am J Hum Genet, vol.80, issue.5, pp.867-875, 2007.

B. A. Lie, M. K. Viken, S. Odegard, D. Van-der-heijde, R. Landewé et al., Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study, Annals of the Rheumatic Diseases, vol.66, issue.12
DOI : 10.1136/ard.2006.067892

F. Rebai, H. Fakhfakh, E. Ayadi, A. Petit-teixeira, and . Maalei, Signal transducer and activator of transcription and the risk of rheumatoid arthritis and thyroid autoimmune disorders, Clin Exp Rheumatol, 2011.

A. T. Masi, S. L. Feigenbaum, and R. T. Chatterton, Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systems, Seminars in Arthritis and Rheumatism, vol.25, issue.1, pp.251-278, 1995.
DOI : 10.1016/S0049-0172(95)80014-X

M. Cutolo, B. Seriolo, B. Villaggio, C. Pizzorni, C. Craviotto et al., Androgens and Estrogens Modulate the Immune and Inflammatory Responses in Rheumatoid Arthritis, Annals of the New York Academy of Sciences, vol.19, issue.1, pp.966131-142, 2002.
DOI : 10.1111/j.1749-6632.2002.tb04210.x

E. M. Sternberg, Neuroendocrine regulation of autoimmune/inflammatory disease, Journal of Endocrinology, vol.169, issue.3, pp.429-435, 2001.
DOI : 10.1677/joe.0.1690429

M. Cutolo, S. Capellino, P. Montagna, P. Ghiorzo, A. Sulli et al., Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line, Arthritis Research & Therapy, vol.7, issue.5, pp.1124-1132, 2005.
DOI : 10.1186/ar1791

J. E. Oliver and A. J. Silman, Risk factors for the development of rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.59, issue.3, pp.169-174, 2006.
DOI : 10.1080/07315724.2002.10719248

K. H. Costenbader, D. Feskanich, L. A. Mandl, and E. W. Karlson, Smoking Intensity, Duration, and Cessation, and the Risk of Rheumatoid Arthritis in Women, The American Journal of Medicine, vol.119, issue.6, pp.503-504, 2006.
DOI : 10.1016/j.amjmed.2005.09.053

S. Y. Bang, K. H. Lee, S. K. Cho, H. S. Lee, K. W. Lee et al., Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DBR1 shared épitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status, Arthritis Rheum, issue.2, pp.62-369, 2010.

. Epstein-barr, virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis, J Rheumatol, vol.27, issue.4, pp.866-873, 2000.

S. S. Deo, R. R. Shetty, K. J. Mistry, and A. R. Chogle, Detection of viral citrullinated peptide antibodies directed against EBV or VCP: In early rheumatoid arthritis patients of Indian origin, Journal of Laboratory Physicians, vol.2, issue.2, pp.93-99, 2010.
DOI : 10.4103/0974-2727.72158

H. Autorité and D. Santé, Polyarthrite rhumatoïde : diagnostic et prise en charge initiale. Synthèse des recommandations, pp.2-9, 2007.

S. W. Syversen, G. L. Goll, D. Van-der-heijde, R. Landewe, B. A. Lei et al., Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study, Annals of the Rheumatic Diseases, vol.69, issue.2, pp.69345-351, 2010.
DOI : 10.1136/ard.2009.113092

. Progrès-dans-la-polyarthrite-rhumatoïde, Revue du Rhumatisme, pp.7414-7435, 2007.

A. Gough, J. Faint, M. Salmon, A. Hassell, P. Wordsworth et al., Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome, Arthritis & Rheumatism, vol.89, issue.8, pp.37-1166, 1994.
DOI : 10.1002/art.1780370809

N. J. Wiles, M. Lunt, E. M. Barrett, A. J. Silman, D. P. Symmons et al., Reduced disability at five years with early treatment of inflammatory polyarthritis: Results from a large observational cohort, using propensity models to adjust for disease severity, Arthritis & Rheumatism, vol.37, issue.5, pp.44-1033, 2001.
DOI : 10.1002/1529-0131(200105)44:5<1033::AID-ANR182>3.0.CO;2-G

J. T. Sharp, D. Y. Young, G. B. Bluhm, A. Brook, and A. C. Brower, How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum, pp.28-1326, 1985.

R. S. Pinals, A. T. Masi, and R. A. Larsen, Preliminary criteria for clinical remission in rheumatoid arthritis, Arthritis & Rheumatism, vol.25, issue.10, pp.1308-1315, 1981.
DOI : 10.1002/art.1780241012

A. College and . Rheumatology, European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials, Arthritis Rheum, vol.63, issue.3, pp.573-586, 2011.

J. Sany, P. Bourgeois, A. Saraux, S. Durieux, A. Lafuma et al., Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists, Annals of the Rheumatic Diseases, vol.63, issue.10, pp.63-1235, 2004.
DOI : 10.1136/ard.2003.013110

F. Wolfe, D. M. Mitchell, J. T. Sibley, J. F. Fries, D. A. Bloch et al., The mortality of rheumatoid arthritis, Arthritis & Rheumatism, vol.18, issue.4, pp.37481-494, 1994.
DOI : 10.1002/art.1780370408

M. F. Doran, G. R. Pond, C. S. Crowson, W. M. O-'fallon, and S. E. Gabriel, Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period, Arthritis & Rheumatism, vol.23, issue.3, pp.46625-631, 2002.
DOI : 10.1002/art.509

I. D. Del-rincon, K. Williams, M. P. Stern, G. L. Freeman, and A. Escalante, High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors, Arthritis & Rheumatism, vol.25, issue.12, pp.442737-2745, 2001.
DOI : 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#

D. H. Solomon, E. W. Karlson, E. B. Rimm, C. C. Cannuscio, L. A. Mandl et al., Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis, Circulation, vol.107, issue.9, pp.107-1303, 2003.
DOI : 10.1161/01.CIR.0000054612.26458.B2

A. M. Stehouwer, J. M. Spijkerman, G. Dekker, R. J. Nijpels, L. M. Heine et al., Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a crosssectional study, the CARRE Investigation, Ann Rheum Dis, issue.9, pp.68-1395, 2009.

. Progrès-dans-la-polyarthrite-rhumatoïde, Revue du rhumatisme, pp.7418-7443, 2007.

. Polyarthrite-rhumatoïde, Société Française de Rhumatologie : flash-conférence 23 e congrès, p.6, 2010.

N. Kusunoki, K. Kitahara, F. Kojima, N. Tanaka, K. Kaneko et al., Adiponectin stimulates prostaglandin E2 production in rheumatoid arthritis synovial fibroblasts, Arthritis & Rheumatism, vol.16, issue.6, pp.621641-1649, 2010.
DOI : 10.1002/art.27450

M. Korpela, L. Laasonen, P. Hannonen, H. Kautiainen, M. Leirisalo-repo et al., Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study, Arthritis & Rheumatism, vol.43, issue.Suppl, pp.50-2072, 2004.
DOI : 10.1002/art.20351

J. J. Anderson, G. Wells, A. C. Verhoeven, and D. T. Felson, Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration, Arthritis & Rheumatism, vol.4, issue.1, pp.4322-4351, 2000.
DOI : 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9

. Polyarthrite-rhumatoïde-Évolutive-grave, Guide-Affection de longue durée, 2008.

H. Autorité and D. Santé, Polyarthrite rhumatoïde, synthèse des recommandations. Recommandations professionnelles, 2007.

J. R. Kirwan, SYSTEMIC LOW-DOSE GLUCOCORTICOID TREATMENT IN RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, vol.27, issue.2, pp.389-403, 2001.
DOI : 10.1016/S0889-857X(05)70208-8

J. A. Wessels, T. W. Huizinga, and H. J. Guchelaar, Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis, Rheumatology, vol.47, issue.3, pp.47249-255, 2008.
DOI : 10.1093/rheumatology/kem279

. Efficacité, tolerance et maintien du méthotrexate dans le traitement des polyarthrites rhumatoïdes. Revue du rhumatisme, pp.34-43, 2002.

K. Visser, W. Katchamart, E. Loza, J. A. Martinez-lopez, C. Salliot et al., Et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative, Ann Rheum Dis, issue.7, pp.68-1086, 2009.

J. S. Smolen, J. R. Kalden, D. L. Scott, B. Rozman, T. K. Kvien et al., Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial, The Lancet, vol.353, issue.9149, pp.259-266, 1999.
DOI : 10.1016/S0140-6736(98)09403-3

R. S. Pinals, S. B. Kaplan, J. G. Lawson, and B. Hepburn, A double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.14, issue.12, pp.1427-1434, 1986.
DOI : 10.1002/art.1780291202

M. Boers, A. C. Verhoeven, H. M. Markusse, M. A. Van-de-laar, R. Westhovens et al., Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis, The Lancet, vol.350, issue.9074, pp.350-309, 1997.
DOI : 10.1016/S0140-6736(97)01300-7

P. Scholte-voshaar, L. Van-riel, and . Gossec, Current evidence for the management of rheumatoid arthritis with synthetic diseasemodifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis, Ann Rheum Dis, issue.6, pp.69-1004, 2010.

. Wolleim, D-penicillamine in early rheumatoid arthritis : experience from a 2-year double blind placebo controlled study, Clin Exp Rheumatol, vol.14, pp.625-631, 1996.

G. Pasero, P. Pellegrini, U. Ambanelli, M. L. Ciompi, V. Colamussi et al., Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis, Arthritis & Rheumatism, vol.70, issue.8, pp.25923-929, 1982.
DOI : 10.1002/art.1780250803

. Polyarthrite-rhumatoïde, Traitements de fond (synthèse des résumés des caractéristiques des produits) Recommandations professionnelles, 2007.

F. Salaffi, M. Carotti, and C. Cervini, Combination Therapy of Cyclosporine a with Methotrexate or Hydroxychloroquine in Refractory Rheumatoid Arthritis, Scandinavian Journal of Rheumatology, vol.10, issue.2, pp.25-41, 1996.
DOI : 10.3109/03009749609082662

P. Tugwell, T. Pincus, D. Yocum, M. Stein, O. Gluck et al., Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group, N Engl J Med, issue.3, pp.333-137, 1995.

. Infliximab, chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group, Lancet, vol.354, issue.9194, pp.1932-1939, 1999.

E. W. St-clair, D. M. Van-der-heijde, J. S. Smolen, R. N. Maini, J. M. Bathon et al., Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial, Arthritis & Rheumatism, vol.48, issue.11, pp.503432-3443, 2004.
DOI : 10.1002/art.20568

Y. F. Chen, P. Jobanputra, P. Barton, S. Jowett, S. Bryan et al., A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their costeffectiveness, Health Technol Assess, issue.42, pp.10-11, 2006.

H. Autorité and D. Santé, Commission de la transparence : Avis Roactemra ®, 2009.

H. Autorité and D. Santé, Commission de la transparence : Avis Mabthera ® http://www.has-sante.fr/portail, 2010.

H. Autorité and D. Santé, Commission de la transparence : Avis Simponi ®, 2012.

. Polyarthrite-rhumatoïde, Prise en charge en phase d'état. Recommandations professionnelles, 2007.

. Principes-de-la-chirurgie-dans-la-polyarthrite-rhumatoïde, La revue du praticien, pp.2158-2159, 2005.

«. Brochure, ANDAR, Polyarthrite rhumatoïde et image de soi, 2004.

M. Cameron, J. J. Gagnier, C. V. Little, T. J. Parsons, A. Blümle et al., Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Phytotherapy research, 2009.

K. L. Soeken, S. A. Miller, and E. Ernst, Herbal medicines for the treatment of rheumatoid arthritis: a systematic review, Rheumatology, vol.42, issue.5, 2003.
DOI : 10.1093/rheumatology/keg183

P. C. Mattingly and A. G. Mowat, Zinc sulphate in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.41, issue.5, pp.456-457, 1982.
DOI : 10.1136/ard.41.5.456

S. Y. Chang, Effects of Aroma Hand Massage on Pain, State Anxiety and Depression in Hospice Patients with Terminal Cancer, Journal of Korean Academy of Nursing, vol.38, issue.4, pp.493-502, 2008.
DOI : 10.4040/jkan.2008.38.4.493

. Conseil-en-aromathérapie, ème édition) Pro-Officina, Reuil-Malmaison, 2008.

J. S. Han, J. Tang, M. F. Ren, Z. F. Zhou, S. G. Fan et al., Central Neurotransmitters and Acupuncture Analgesia, The American Journal of Chinese Medicine, vol.08, issue.04, pp.331-348, 1980.
DOI : 10.1142/S0192415X80000311

]. B. Wechsler and O. Chosidow, Corticoïdes et Corticothérapie, John Libbey Eurotext, issue.140, 1997.

H. Hôpital and . Mondor, Alimentation et corticothérapie, p.6, 2012.

D. Et-polyarthrite-rhumatoïde, ANDAR infos n°41 JPM éditions, Saint-Etienne-De- Fursac, 2009.

D. Alimentation and P. Dans-la, Société Française de Rhumatologie : flash-conférence 18 e congrès, 2005.

R. A. Harrison and B. J. Harrison, Fish oils are beneficial to patients with established rheumatoid arthritis, J Rheumatol, vol.28, issue.11, pp.2563-2565, 2001.

G. Smedslund, M. G. Byfuglien, S. U. Olsen, and K. B. Hagen, Effectiveness and Safety of Dietary Interventions for Rheumatoid Arthritis: A Systematic Review of Randomized Controlled Trials, Journal of the American Dietetic Association, vol.110, issue.5, pp.110727-735, 2010.
DOI : 10.1016/j.jada.2010.02.010

E. O. Lee, J. I. Kim, A. H. Davis, and I. Kim, Effects of Regular Exercise on Pain, Fatigue, and Disability in Patients With Rheumatoid Arthritis, Family & Community Health, vol.29, issue.4, pp.29320-327, 2006.
DOI : 10.1097/00003727-200610000-00010

P. Gaudin, S. Leguen-guegan, B. Allenet, A. Baillet, L. Grange et al., Is dynamic exercise beneficial in patients with rheumatoid arthritis? Joint, Bone, Spine : revue du rhumatisme, pp.7511-7528, 2008.

L. Abbott and ®. , Parcours bon usage anti-TNF?, p.6, 2012.

A. Trousseau, CRAT : Centre de Renseignements sur les Agents Tératogènes, p.6, 2012.

. Ax-les-thermes, Ariège -09) Bagnoles-de-l'Orne (Orne -61

. Bains-les-bains, Vosges -88) Balaruc-les-Bains (Hérault -34) Barbotan-les-Thermes (Gers -32

. Bourbonne-les-bains, Haute-Marne -52) Brides-les-Bains (Savoie -73)

. Châtel-guyon, Puy-de-Dôme -63) Cilaos (Ile de la Réunion -974) Cransac-les-Thermes (Aveyron -12

. Jonzac, Charente-Maritime -17) Lamalou-Les-Bains

. Mont-dore, Puy-de-Dôme -63) Morsbronn-les-Bains (Bas-Rhin -67) Neyrac-les-Bains (Ardèche -07) Niederbronn-les-Bains (Bas-Rhin -67) Néris-les-Bains (Allier -03) Pietrapola-les-Bains (Haute-Corse -2B) Plombières-les-Bains (Vosges -88) Préchacq-les-Bains (Landes -40

. Royat-chamalières, Puy-de-Dôme -63) Saint-Amand-les-Eaux (Nord -59) Saint-Claude Matouba-Papaye

. Salies-du-salat, Haute-Garonne -31) Salins-les-Bains (Jura -39)

. Saubusse-les-bains, Landes -40) Tercis-les-Bains (Landes -40)

. Vernet-les-bains, Pyrénées-Orientales -66) Vichy (Allier -03) Vittel (Vosges -88